I am biased as I hold shares. This reply assumes you have some knowledge of Flomerics.
Flomerics has a world-class product that is supplies to a number of Electronic and Computer Giants. A high percentage of its turnover occurs in the US and because a number of its customers have put out profit warnings, and hence their share price has fallen, then Flomerics has also fallen.
Flomerics does have seasonality in that a large number of its recurring revenues are signed up in the second half of its financial year, until 31.12.00. Markets don't like uncertainty and the fear that it generates. Some people may be worried that its customers will try and squeeze margins or cancel orders. My own opinion is that this is unlikely. As long as Flomerics current thermal product cuts down on the time taken for a product to get to market and as long as this is not detrimental to a company's current operations will always be bought. The cost to its customers is negligible in relation to the costs saved and potential revenue gained by getting a product to the market quicker. As evidenced by the fact that after four years of trading it made a profit in the first half of this year (six months to 30.6.00), for the first time.
Also, if you look at the volume of shares traded, a negligible number, then I personally am not worried. As the shares are tightly held be a number of institutions and company personnel they are relatively illiquid and so volatile. Adverse sentiment affects the share price, as shown, and so it falls. But because it is volatile then it will rebound just as quickly when favourable news flow comes through.
I believe this will be when it announces the successful launch of its ‘magnetic’ product. Components, which suffer thermal issues, also suffer magnetic problems. This new product received favourable reviews when demonstrated and already Hewlett Packard has signed up for it. A number of other companies are said to be waiting in the wings. This product was said to be out by the end of September and so over the next few weeks we should learn of its launch. Flomerics are serious about this product as evidenced by an important member of their management team from the acquisition of Kimberley Communications Consultants being relocated to America a couple of months ago (I forget the name).
Flomerics is a company with a world class global product, which has recurring revenues, high margins, an impressive management team and a new product which it should be able to cross sell to existing clients at relatively little extra cost, and the new product should assume just as much importance as its thermal product, within 18 months of its launch.
(I am a Novice Investor. This is not intended as Investment Advice. If you wish to buy or sell shares please seek the advice of an Independent Financial Advisor before doing so).